Labcorp to speak at the UBS 2022 Global Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May 17, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that members of the executive management team will participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Tuesday, May 24 at 2:45 p.m. ET.

Labcorp launches first-of-its-kind at-home collection device for diabetes risk testing

BURLINGTON, N.C. --(BUSINESS WIRE)--May 16, 2022-- There is a new and convenient way for millions of individuals to assess whether they are at risk for developing diabetes.

Jeffrey Albrecht

Dr Albrecht earned his PhD in microbiology and molecular genetics from the University of California at Los Angeles. He also holds New York state certification of qualification in genetic testing and is licensed in California as a clinical genetics molecular biologist scientist.

Labcorp acquires diagnostic clinical laboratory services from AtlantiCare

BURLINGTON, N.C. , and EGG HARBOR TOWNSHIP, N.J. --(BUSINESS WIRE)--May 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, today announced that they have closed a transaction to expand their long-term strategic relationship.